There were 54 press releases posted in the last 24 hours and 221,767 in the last 365 days.

Federman & Sherwood Reminds Investors of Imminent Lead Plaintiff Deadline in Securities Class Action Lawsuit Against Myriad Genetics, Inc.

/EIN News/ -- OKLAHOMA CITY, June 04, 2018 (GLOBE NEWSWIRE) -- On April 20, 2018, a class action lawsuit was filed in the United States District Court for the District of Utah against Myriad Genetics, Inc. (NASDAQ:MYGN).  Federman & Sherwood reminds current and former shareholders of Myriad Genetics, Inc. that they only have until Tuesday, June 19, 2018 to move the court for appointment as a lead plaintiff in this case.  The Complaint alleges violations of Section 10(b) and Section 20(a) of the Securities Exchange Act, and Rule 10b-5 promulgated thereunder.

If you purchased Myriad Genetics, Inc. shares between August 13, 2014 and March 12, 2018, have large losses as a result of your trades during this time period, and wish to join this litigation as a potential lead plaintiff, please contact our office as soon as possible.  Our firm seeks to recover damages on behalf of the Class.  Federman & Sherwood has extensive experience and expertise in prosecuting securities litigation involving financial fraud.  We represent investors throughout the country in shareholder litigation.

William B. Federman
FEDERMAN & SHERWOOD
10205 North Pennsylvania Avenue
Oklahoma City, OK 73120
(405) 235-1560/Fax: (405) 239-2112
Email to: wbf@federmanlaw.com - www.federmanlaw.com

Primary Logo